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Abstract— Although some methods are proposed for automatic ontology generation, none of them address the issue of 
integrating large-scale heterogeneous biomedical ontologies. We propose a novel approach for integrating various types of 
ontologies efficiently and apply it to integrate International Classification of Diseases, Ninth Revision, Clinical Modification 
(ICD9CM) and Gene Ontologies (GO). This approach is one of the early attempts to quantify the associations among clinical 
terms (e.g. ICD9 codes) based on their corresponding genomic relationships. We reconstructed a merged tree for a partial set 
of GO and ICD9 codes and measured the performance of this tree in terms of associations’ relevance by comparing them with 
two well-known disease-gene datasets (i.e. MalaCards and Disease Ontology). Furthermore, we compared the genomic-based 
ICD9 associations to temporal relationships between them from electronic health records.  Our analysis shows promising 
associations supported by both comparisons suggesting a high reliability. We also manually analyzed several significant 
associations and found promising support from literature. 
Index Terms— knowledge integration, clinical records, Gene Ontology 
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1 INTRODUCTION
UTOMATIC ontology generation and integration are
desirable in many applications and have been studied
in the past decade. Although available methods for auto-
matic ontology generation produce ontologies from a sin-
gle type of data, such as gene networks [1], textual data [2], 
dictionary [3] and schemata [4], [5], they do not contribute 
to the integration of different types of ontologies which 
will bring innovative results on annotation/knowledge re-
use and association studies. A number of studies have been 
focused on ontology integration [6], [7] and their medical 
domain applications[8]. The ontology integration methods 
are generally classified into three categories:  1) Manual set 
up of the integration rules [9]; 2) Heuristic approaches for 
automatic ontology integration[10], [11], [12], [13]; 3) Ma-
chine learning methods to assist the automatic ontology in-
tegrations [14]. These methods have a few major weak-
nesses including: 1) lack of efficient or systematic ap-
proaches to identify similarity between heterogeneous on-
tology concepts; 2) generally heuristic with no theoretical 
results to show the proposed integration approach is glob-
ally optimal; 3) they are not developed for integrating big 
ontologies or a large number of ontologies. 
Our recent work on the UMLS (Unified Medical Language 
System) indexing [15] and UMLS mapping [16] allowed us 
to make necessary preparations for the heterogeneous on-
tology integration. The UMLS is a network of biomedical 
terms whose size and density exceeds the capacity of pre-
vailing distance indexing methods for general graphs[17], 
[18]. However, by observing the scale-free structure of the 
UMLS network, we are able to index it by iteratively re-
moving high degree vertices from the UMLS network and 
assign their labels to vertices within their k neighborhoods. 
We name such an approach k-Decentralized Labeling 
Scheme (kDLS) [15]. We demonstrated that we are able to 
use kDLS to efficiently evaluate the closeness between any 
two UMLS terms via the discovered paths between them. 
Later, we developed onGrid [15] to advance the kDLS 
method, by considering concept semantic types in the con-
cept closeness measurement. The advantages of onGrid 
over kDLS were demonstrated in [15]. In order to use kDLS 
or onGrid to study the relationships between biomedical 
concepts, we also need an efficient tool to map biomedical 
concepts to UMLS terms. However, we found that availa-
ble methods, MetaMap [19], cTAKES [20], and the UMLS 
Metathesaurus Browser, either fail to consider a biomedi-
cal concept as a whole, or fail to tolerate character varia-
tions in words. Thus, we developed a layered dynamic 
programming approach (LDPMap) [16] that is able to effi-
ciently map a biomedical concept to a UMLS term by meas-
uring the similarity between biomedical terms at both the 
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word and concept levels. As a result, given any two bio-
medical ontologies, we are able to use LDPMap (for non-
UMLS ontologies) and onGrid[15] to generate a relation-
ship matrix which provides 1) a systematic measurement 
to quantify the goodness for the ontology integration; 2) 
theoretical results to show that the proposed integration 
approach is globally optimal or close to optimal; 3) capa-
bility for integrating large volume of ontologies. We have 
previously demonstrated that these newly developed algo-
rithms are efficient and provide optimal or near optimal 
solutions for integrating large ontology datasets [25]. Each 
entry in the relationship matrix is a value of closeness 
measurement between the corresponding two concepts.  
Briefly, as described earlier [25], the basic ontology integra-
tion problem in our work can be formulated as follows. 
Given ontology tree structures TA and TB and a closeness 
based relationship matrix MAB, integrated ontology tree 
structure should meet the following two basic criteria. 
1) For any two vertices x and y in TA (or TB), the low-
est common ancestor LCA TA (x,y) (or LCA TB 
(x,y)) is contained by LCA TAB (x,y).
2) It holds that argmax TAB f(TAB)=∑XЄV(TAB) MAB(X).
Here MAB(X) is the entry value in the closeness
matrix for the corresponding two vertices (one
from TA and the other from TB) contained in the
node X. MAB(X)=0 if X, a node of TAB, contains only
one vertex from TA or TB.
We name f(TAB) the cohesion function of the integrated on-
tology TAB  and its value is the overall cohesion score of in-
tegrating TA and TB  into TAB. Correspondingly, we define 
function g(TA, TB)=maxTAB(∑vЄV(TAB) MAB(v)) as the maxi-
mum cohesion function for integrating the ontologies TA 
and TB and its value is the maximum overall cohesion score 
(or, simply, maximum cohesion score). Consequently, we 
will assume that for any two given ontologies, their rela-
tionship/similarity matrix discussed in section 2.1 is avail-
able for calculating the cohesion score.  
Our approach is innovative in three fundamental aspects: 
1) We designed onGrid[15] and LDPMap[16] to efficiently
generate similarity matrix between two sets of heterogene-
ous biomedical ontologies; 2) Given a similarity matrix be-
tween two sets of ontologies, we are able to identify an  op-
timal solutionfor integrating the two ontologies; 3) Our 
methods can integrate big ontologies and can be extended 
to integrate a large number of ontologies. However, it is 
important to note that this work is a proof of concept for 
the original approach developed earlier and only a small 
fraction of GO dataset is integrated at this stage. In addi-
tion, our results demonstrate that it is possible to use the 
merged biomedical ontologies and derived annotations 
generated by our methods for biomedical knowledge dis-
covery.  
Each ontology has a hierarchical structure which is often 
recorded in paths. In the UMLS, the file "MRHIER.RRF" 
records each path from an ontology term to its root. Hence, 
we can build an ontology tree (sometimes it is a forest) 
upon these paths. Such a tree maintains the ancestry-de-
scendent relationships among its concepts. In other words, 
a concept A is an ancestor of another concept B in a path, if 
and only if A is the ancestor of B in the ontology tree. When 
merging two ontologies, the basic constraint is that ances-
tor-descendent relationships are preserved. That is, for any 
two concepts A and B in an ontology tree, if A is the ances-
tor of B, then this is also true in the merged ontology tree. 
This is reasonable otherwise the results are illogical. Under 
such a basic constraint, our goal is to generate a merged 
ontology tree for ICD9 codes and Gene Ontology (GO) da-
taset that maximizes the closeness scores.  
One of the fundamental problems in biomedical sciences is 
to link the phenotype with the genotype of an organism. 
However, most of the existing clinical systems only pro-
vide phenotypic information i.e, disease or clinical mani-
festation of a patient’s ill health with very limited geno-
typic cause being provided. One approach to address this 
fundamental gap in our knowledge and a step closer to-
wards personalized medicine is to map clinical manifesta-
tions on to the underlying tissue-specific genotypes.  In an 
effort to address this gap, we have attempted to use the 
proposed ontology integration framework using UMLS as 
the backbone, to transfer GO annotations for the human 
genome to ICD9 annotations, thereby facilitating the map-
ping of disease codes and clinical manifestations to the un-
derlying genes, pathways and processes. We anticipate 
that with improvements in annotations for the human ge-
nome at the molecular and cellular level, it should be pos-
sible to accurately map the gene pool contributing to a clin-
ical manifestation in an automated fashion by deploying 
frameworks such as those proposed in this study. 
2 MATERIALS AND METHODS 
2.1 Systematic method for heterogeneous ontology 
integration and evaluation 
Ontologies are important knowledge entities existing in 
many areas of biomedical research. The UMLS contains 
many popular ontologies such as Gene Ontology (GO), In-
ternational Classification of Diseases, Ninth Revision, 
Clinical Modification (ICD9CM), and Medical Dictionary 
for Regulatory Activities Terminology (MedDRA).  These 
ontologies have been widely used in many biomedical ap-
plications. For example, GO has been used in designing 
TOPPGENE [21], a popular gene enrichment validation 
method, and ICD9CM has been used in many electronic 
health record (EHR) systems. However, despite the rich in-
formation provided by existing ontologies, they are only 
focused on the narrow knowledge domain of their own. 
The GO is annotated with gene information while the 
ICD9CM is annotated with disease and clinical infor-
mation. There is no information sharing between these on-
tologies. 
A significant amount of work in biomedical research is to 
identify the associations between different entities, such as 
identifying disease genes [22], prioritizing disease genes 
[23], and mapping phenotypes to genotypes [24]. These 
works will not benefit from a single ontology. If we can re-
use (or map) the annotation of one ontology to another, it 
will significantly contribute to the study of various associ-
ations. In addition, not all ontologies are as well-studied as 
the most popular ontologies like GO. The ability to use the 
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annotation of one ontology to another will significantly fa-
cilitate our understanding on less studied ontologies. 
However, ontologies are often very large. GO, for example, 
contains over 300k terms. Manually integrating two ontol-
ogies is often too costly to be feasible, not to mention in real 
applications we may need to integrate many pairs of ontol-
ogies.  
Available methods on ontology integration have several 
major weaknesses for effectively integrating biomedical 
ontologies in a large scale, as discussed earlier. To address 
this challenging problem, we designed a systematic ap-
proach on efficiently integrating large scale ontologies[25] 
. Our approach is built upon our past work on indexing the 
UMLS by decentralization labeling schema [15] and map-
ping concepts to the UMLS terms[16]. Using LDPMap and 
onGrid[15], we are able to map biomedical concepts to the 
UMLS CUIs (i.e, Concept Unique Identifiers), and generate 
relationship/similarity matrix between two sets of bio-
medical terms based on the discovered UMLS paths (tran-
sitive relationships) between them. The discovered UMLS 
paths between the concepts are measured as closeness val-
ues in this network, in order to construct a relation-
ship/similarity matrix between the corresponding con-
cepts. The workflow for generating similarity matrix is il-
lustrated in the left part of Figure 1. If a biomedical ontol-
ogy is chosen from the UMLS, then the LDPMap process 
can be skipped because each ontology term already has a 
CUI. With the generated similarity matrix, we are able to 
build an integrated ontology with a score of merging the 
two ontologies, as illustrated in the right panel of Figure 1. 
To get a maximum merging score, we can simply choose 
the maximum values in the similarity matrix and build the 
merged ontology correspondingly. However, by doing so 
we may get a merged ontology which violates the basic 
logic in the original ontology, such as the reverse of ances-
tor-descendent relationship. Therefore, our method bal-
ances the effort between maximizing the merging score 
and maintaining the basic hierarchical logic in the original 
ontologies. We realized this by a bottom-up approach 
which iteratively calculates the merge score for terms in 
the two ontologies in the reverse topological order. For ex-
ample, when we calculate the merge score for term1a and 
term2a, the merge scores must have already been calcu-
lated between all terms with topological orders greater 
than term 1a in ontology 1 (i.e., term1b, term1c, term1d, 
term1e, term1f), and all terms with topological orders 
greater than term 1b in ontology 2 (i.e., term2b, term2c, 
term2d, term2e, term2f). As illustrated in Figure 1, before 
an entry in the merge score matrix is calculated, all entries 
up and left to this entry should have been calculated. How-
ever, the order of calculation is not unique. It is valid as 
long as it follows the reverse topological order. In the fol-
lowing text, we elaborate the major steps for integrating 
two given ontologies assuming their similarity matrix is 
available for identifying the ontology integration.  
Step 1: Sort terms in ontology 1 and terms in ontology 2 in 
the reverse topological order; 
Step 2: Initialize an empty merge score matrix whose row 
and column correspond to the sorted terms in ontology 1 
and ontology 2; 
Step 3: Pick up a pair of terms (term1x, term2y) in the 
sorted order; 
Step 4:  Calculate the maximal matching score MM be-
tween the children of term1x and the children of term2y; 
Step 5: Let score(term1x, term2y)=max(MM+sim(term1x, 
term2y), maxi(score(i, term2y)), maxj(score(term1x, j)); 
where i and j are the indices of the terms upper or left of 
term1x and term2y respectively in the matrix. 
Step 6: Allow term1x and term2y merge if 
MM+sim(term1x, term2y) is greater than maxi(score(i, 
term2y)) and maxj(score(term1x, j); 
Step 7: Repeat from Step 3 if (term1x, term2y) is not the last 
pair in the sorted order; 
Step 8: Output the integrated ontology. 
Step 4 is a main process in the ontology integration. It de-
termines the merging of children of term1x and term 2y for 
a maximal merge score MM. This can be achieved by iter-
atively selecting two child terms with maximal merge 
score, a process of matching child terms. If 
MM+sim(term1x, term2y) is greater than any scores in the 
score matrix upper or left to (term1x, term2y),  then it sug-
gests that merging term1x and term2y is the best choice in 
integrating the subtree rooted at term1x and the subtree 
rooted at term2y. Otherwise, it implies either merging 
term1x with a descendant term of term2y, or merging 
term1y with a descendant term of term1x, is the best choice 
in integrating the subtree rooted at term1x and the subtree 
rooted at term2y. Since we iteratively get the best choice 
for integrating each pair of subtrees, we eventually get the 
best choice for integrating ontology 1 and ontology 2. We 
found such a bottom-up approach works very effectively 
in integrating biomedical ontologies. However, the 
method is also limited by the memory size as we need to 
build matrices with sizes proportional to the product of the 
two ontology sizes. 
In this study, we employed the above ontology integration 
framework to merge two different hierarchical annotation 
systems namely International Classification of Diseases, 
Ninth Revision (ICD9) codes and Gene Ontology (GO). 
ICD9CM (International Classification of Diseases, 9th edi-
tion, Clinical Modification) is a set of codes used by physi-
cians, hospitals, and allied health workers to indicate diag-
nosis for all patient encounters. 
In particular, we have implemented these basic algorithms 
in C++ and applied it on GO and ICD9CM, two popular 
ontologies in the UMLS. Our current implementationis 
limited by the memory size and is currently not able to 
handle extremely large ontologies. For instance, to com-
plete the integration of the full GO and ICD9CM ontolo-
gies, it will take months to compute on a large memory ma-
chine. We plan to speed up the process in the future by de-
veloping distributed algorithms that work in a cloud com-
puting environment. In this study, we used a subset of GO 
(a subtree from its root to vertices at depth 7) which in-
cludes 39,800 GO terms (out of a total of 333,507 terms) and 
the full set of ICD9CM which includes 22,401 terms. 
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2.2 Evaluation of the integration of ICD9 and GO to 
study the efficiency and effectiveness of the 
merged ontology and derived annotations 
While it is not possible to obtain absolute gold stand-
ards (especially for disease annotations) to evaluate the ef-
ficiency and effectiveness of the merge process, due to var-
ious reasons including the semi-automatic curation efforts 
commonly employed, disease specific biases inherent in 
the databases, and lack of negative annotations for a dis-
ease etc., employing multiple datasets for evaluation of the 
annotations can be considered as a robust means to verify 
the quality and effectiveness of the merging process. Un-
der this notion, we constructed the ICD9 to gene associa-
tions in the human genome by using the ICD9->GO rela-
tions derived, by employing our merging algorithm as a 
means to identify the genes contributing to the dis-
ease/phenotype with a given ICD9 code. Such predicted 
ICD9 to gene annotations come from transferring the gene 
annotations to ICD9 codes via GO IDs based on the inte-
grated ontology on the UMLS. This data was used for eval-
uation of the merging process by studying enrichments 
comparing with the disease to gene annotations currently 
available from Disease Ontology (DO)[28] and 
MalaCards[29] databases, as they form two domain spe-
cific high-throughput datasets currently available for stud-
ying disease to gene annotations. To perform enrichments, 
we computed the overlap between the annotated ICD9 to 
gene associations from these resources and those discov-
ered by our approach to calculate the hyper geometric 
probability of the overlap. P-values and corresponding sig-
nificance values computed from them are used as statisti-
cal measures of our ability to reproduce the known associ-
ations. In particular, we performed the enrichments be-
tween our mapping for each ICD9 to gene annotations and 
these database annotations for the corresponding diseases 
to genes by calculating the hypergeometric probability of 
overlap. Similar statistical approach was adopted for com-
puting enrichments when comparing predicted ICD9-
ICD9 associations with the temporal ICD9-ICD9 associa-
tions data used in Section 3.3.   Since these resources do not 
have true negative information, performing enrichments is 
a better approach as opposed to Receiver Operating Char-
acteristics (ROC) analysis.   
3 RESULTS 
3.1 Benchmarking the annotations resulting from 
integrated ontology with external databases 
Figure 2 shows a sample of the integrated ontology with 
the relationships among ICD9 and GO annotations pre-
sented as ancestry and sibling associations along with all 
the shortest paths showing other UMLS ids contributing to 
the merge in this sub-tree. The generated network is easily 
interpretable and it can uncover the knowledge associated 
between ICD9 codes and their corresponding GO annota-
tion terms. The network is modeled as directed network 
where a flow of information is originating from an ICD9 
term and ends in a GO term. For example:   
C0023448:Lymphoid leukemia  C1512385:Hematopoietic and 
Lymphoid Cell C0007634:Cell C1156236:Inhibition of Cell 
Proliferation  C1655747:negative regulation of cellular pro-
cess 
One potential interpretation of this shortest path between 
C0023448 (ICD9 code) and C1655747 (GO term) can 
demonstrate that “Lymphoid leukemia is originated from 
Hematopoietic Lymphoid cell and is associated with cell 
proliferation which is a negative regulation process.”  In 
another example:  
C0153436:Malignant neoplasm of sigmoid colon  
C0007102:Malignant tumor of colon  C0385939:SMAD4 
protein, human  C0007586:Cell Cycle C1659594:positive 
regulation of cell cycle 
Similarly, the extracted path between C0153436 (ICD9 
code) and C1659594 (GO term) which was present in the 
integrated ontology implies that “Malignant neoplasm of 
sigmoid colon is a tumor associated with malfunction of 
SMAD4 protein which consequently results in the positive 
regulation of cell cycle.”   
Previous examples demonstrated potential novel associa-
tions that can be extracted using this framework. Although 
verifying the associations requires further analysis, we ver-
ified the sample associations with literature and found ex-
perimental support. For example, Smurf2 [26] gene is 
known to be associated with tumor repressing mechanism 
and it is reported to influence Hodgkin’s disease and was 
found to be annotated with various components of global 
cellular regulation in GO (e.g. death, differentiation, aging, 
adhesion). In another example, ST13 [27] is shown to be in-
hibiting colorectal cancer in cell lines that are directly asso-
ciated with Malignant neoplasm of colon and Leukemia 
diseases. It is also reported that ST13[27] is associated with 
multiple global cellular regulatory pathways such as 
growth, morphogenesis and proliferation and our inte-
grated ICD9 and GO annotation tree supports the mapping 
between these neoplasmic states and the cell regulation 
processes. 
To further evaluate the quality of our disease to gene an-
notations, we integrated the GO annotations for humans 
(obtained from www.geneontology.org) with ICD9 codes, 
to construct a confident set of ICD9 to gene annotations for 
220 ICD9 codes with varying number of genes associated. 
We then obtained disease to gene associations for the same 
set of ICD9 codes from the MalaCards[29] and Disease On-
tology[28] datasets which are semi-automatically curated 
resources with disease-genotype information. MalaCards 
integrates various disease annotations (e.g. associated 
genes, therapeutics, anatomical context, disease classifica-
tions etc.) for nearly 10000 reported diseases in the litera-
ture. It contains more than 8100 diseases that are associated 
with 38000 non-unique ICD9 codes. Similarly, Disease On-
tology (DO) datasets integrate several ontologies such as 
Medical Subject Headings (MeSH), ICD, Systematic No-
menclature of Medicine (SNOMED) and Online Mendelian 
Inheritance in Man (OMIM). It covers the annotations for 
8700 diseases associated with 8300 ICD9 codes. The num-
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ber of associated ICD9 and Genes are much lower in com-
parison to the MalaCards dataset. In order to increase the 
ICD9 association coverage in DO, we added the missing 
ICD9 codes from MalaCards to DO for the disease with 
same names. The improved DO dataset contained 27,500 
non-unique ICD9 codes. We hypothesized that the confi-
dent ICD9 codes and their associated genes resulting from 
our approach should have a significant overlap with their 
corresponding diseases in both MalaCards and DO da-
tasets. We removed the diseases from both MalaCards and 
DO that are associated with less than five genes. The re-
maining sets comprised of 2990 and 905 diseases for 
MalaCards and DO respectively. We then compared the 
extent of overlap in the gene sets between every possible 
ICD9 code and its corresponding disease to gene annota-
tions in MalaCards and DO respectively. Since the merge 
between ICD9 and GO is not a complete merge of the entire 
ontologies, we believe studying the enrichment of disease-
gene annotations in a disease centric manner using the 
known annotation resources like MalaCards and DO is a 
suitable approach to test the quality of our integration. 
While we don’t intend to suggest that this is the only way 
to test the quality of our ICD9 to gene annotations, to our 
knowledge this is an ideal validation given the limited 
manually curated data in this domain. Out of a set of 112 
diseases (50% of the total initial set of 220) which had at 
least 10 genes annotated in our final dataset, we found 27 
and 17 diseases (Tables 1 and 2) to be significantly enriched 
(Hypergeometric) based on the associated genes docu-
mented in the MalaCards and Disease Ontology resources 
respectively. Our results suggest that the proposed ap-
proach is able to associate the correct GO to its correspond-
ing ICD term as is evident from the high extent of overlap 
of gene sets based on the available annotations for these 
ICD9 codes in MalaCards and Disease Ontology resources. 
While our approach is not able to recover all the annotated 
genes based on our integration, it is possible that the par-
tial integration of the ontologies is contributing to the poor 
coverage. Although MalaCards takes advantage of richer 
and more accurate annotation in comparison to Disease 
Ontology, we found 10 ICD9 codes (diseases) to be signifi-
cant in our comparison with both the datasets  (p< 0.01, 
Hypergeometric test) (Figure 3). These observations show 
that the genes under a given ICD9 code using our ap-
proach are usually enriched for the same disease using dif-
ferent disease annotation resources currently available. For 
instance, we found ICD9 codes associated with leukemia, 
hepatitis, asthma, colitis and colon cancer to be abundant 
in the diseases which exhibited significant overlap be-
tween our predictions and current annotations. It is possi-
ble that our observed prevalence of some of these diseases 
might reflect a bias in current annotations for certain dis-
eases or due to the incomplete merge of ICD9-GO accom-
plished in this study and not necessarily due to the better 
performance of the integrated ontology on certain dis-
eases.  
Although our results show that for about 25% of the ICD9 
codes with considerable number of genes annotated in our 
merged tree, our performance compares well to 
MalaCards and DO datasets, we also found that a number 
of ICD9 codes didn’t show a significant overlap of genes. 
While various possibilities exist including 1) the fact that 
our merge is not complete (only a fraction of GO tree was 
merged with ICD9), 2) certain diseases might be more com-
monly studied and hence are likely to have higher number 
of annotations which may not all be true associations in ex-
isting databases and 3) finally the number of genes anno-
tated for a given ICD9 code can also play a role given the 
incomplete disease annotations present in the databases. 
To evaluate the third scenario, we compared the number 
of genes annotated for highly significant (p< 0.01, Hyper-
geometric test) and non-significant (same number of dis-
eases with high p-values) ICD9 codes in this comparison 
with our disease datasets (Figure 4). It is evident in all the 
three resources that higher the significance for overlap the 
higher was the number of genes, suggesting that lower 
overlap can be mainly due to incompleteness or fewer an-
notations in either of the two data resources being com-
pared. These observations encourage the need to improve 
the coverage of the number of annotations by possibly ex-
panding the GO levels to identify more disease to gene as-
sociations in our mapping framework. 
3.2 Uncovering associations between diseases 
using the gene annotations to ICD9 codes 
In order to further evaluate the quality of our associations, 
we compared the extent of overlap in genes between every 
pair of ICD9 codes in our mapped dataset, for a set of dis-
eases which also exhibited highly significant enrichment 
for corresponding disease annotations in MalaCards and 
DO respectively. This resulted in association networks be-
tween ICD9 codes (Figure 5). We identified 34 and 19 sig-
nificant associations (Hypergeometric) among the ICD9 
codes for MalaCards (Figure 5A) and DO (Figure 5B) over-
lapping disease sets respectively. Although the generated 
networks are from independent annotation datasets, inter-
estingly, there is a notable overlap between the associa-
tions of the two networks (i.e 9 associations) which indi-
cates that our ontology integration method is one of the 
promising efforts in merging the annotations from various 
ontologies. Moreover, the associations also suggest the po-
tential genomic linkages uncovered from our integration 
between diseases, like hodgkin’s sarcoma and malignant 
neoplasm of colon[30] , malignant neoplasm of larynx and 
hemangioma of unspecified site[31], [32] as well as liver 
necrosis and obstruction of bile duct [33], [34], [35]. These 
results suggest that our integrated ontology framework 
can be used to not only transfer annotations from one level 
to the other but can also facilitate comparison and under-
standing of relationships between the annotated groups at 
higher levels. Thus, we believe the extension of our pro-
posed integration framework would enable the discovery 
of novel disease-disease associations based on the sharing 
of genotypic information. 
3.3 Comparison of genomic based ICD9 
associations with temporal relationships based 
on electronic medical records 
We showed that our results have a high overlap with cur-
rently well-known annotations linking diseases with 
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genes, however ICD9 codes are generally assigned based 
on clinical indications of diseases and it is possible to argue 
that diseases which are functionally associated based on 
sharing of genes may not be of clinical relevance. Hence, 
we asked whether ICD9 codes which were found to be as-
sociated due to sharing of genes could also have clinical 
relevance. In particular, we explored the overlap of ge-
nomic-based associations between ICD9 codes with those 
identified based on their linkages calculated by temporal 
relationships in electronic medical records. A recent study 
[36] from University of Michigan calculated the temporal 
relationships among the ICD9 codes based on the elec-
tronic medical records (EMRs). They extracted the pair-
wise associations among ICD9 codes employing X2 test 
and temporal data from the time stamps of the ICD9 codes 
and reported a total of 400000 top associations among the 
occurring ICD9 codes in the EMRs. We used this data to 
question if these epidemiological relationships between 
ICD9 codes can be captured based on our genotypic evi-
dence i.e, sharing of annotated genes between ICD9 codes 
from the integrated ontology - as an aternate means of 
studying the quality of our integration. Since we did our 
analysis with a sample set of 220 ICD9 codes, we extracted 
the set of all associations among the same set from the tem-
poral relationship dataset and we were able to retrieve 62 
temporal associations. We assumed that ICD9-ICD9 asso-
ciations reported based on temporal relationships are in-
deed the truly reported ones. We examined the quality of 
our predictions by comparing the overlap with their pre-
dictions. We calculated significance of overlap of two sets 
by assuming given global number of possible ICD9-ICD9 
associations, whether the observed overlap is by chance. 
We calculated the significance value using hypergeometric 
distribution for the overlap of 45 MalaCards and DO asso-
ciations between our result and the assumed gold stand-
ard. We found 15 significantly shared associations between 
our data and the temporal associations reported between 
ICD9 codes in the U. Michigan dataset (P-value<1e-32, Hy-
pergeometric) (Figure 6 and Table 3).   
To further test whether the predicted ICD9 to gene associ-
ations can be used to identify higher order literature qual-
ity interactions between diseases, we surveyed literature in 
support of these interactions. We found a strong support 
in the literature for several overlapping associations. For 
instance, Advair is one of the primary medicines for treat-
ing the patients with Asthma (C0004096), however, it is re-
ported that oral candidiasis (C0006840) is one of the side-
effect of this treatment [37]. A study [38] reported a 45-
years old woman with increasing retrosternal tenderness 
as well as esophagitis (C0014868) that had benign tumor 
classified as cavernous haemangioma (C0018916). Another 
study[39] constructed a murine experimental model of bile 
duct obstruction that facilitates the controlled observations 
of the acute and subacute phases of cholestasis suggesting 
a strong association between acute and subacute necrosis 
of liver (C0001308) and obstruction of bile duct (C0008370). 
Several diseases might share underlying genotypes how-
ever our knowledge about their relationships is far from 
limited and these results supported by literature evidence 
strengthen our approaches ability to uncover such diseae-
disease associations through automated mining tech-
niques.  More generally, these studies support the rele-
vance of the genomic-based ICD9 associations identified 
using our framework in a translational clinical context.  
4 CONCLUSION AND DISCUSSION 
We proposed a novel approach for merging the annota-
tions from multiple ontologies and applied it for integrat-
ing ICD9 and GO ontologies as a proof of concept.  We 
showed that the associations obtained from the integrated 
tree are significantly enriched for annotations in compari-
son with MalaCards and Disease Ontology datasets. Alt-
hough our integrated ontologies revealed promising asso-
ciations with the genes, number of the associated genes 
plays an important role in our results. Therefore, it might 
be interesting to see how the impact of adding various lev-
els of GO annotations would contribute to our integration 
framework as increasing the levels might increase the cov-
erage of the annotations. To address this, we plan to de-
velop a distributed algorithm that works in a cloud com-
puting environment, and divide the ontology integration 
into sub tasks each with less resource requirement. More-
over, the quality of genes associated with each ontology 
can be measured by use of biological networks such Pro-
tein-Protein Interaction (PPI) networks. This potential 
layer of verification might help to eliminate the genes that 
are associated due to wrong annotations. Improving the 
coverage of our integration framework to build a global 
ICD9 to GO mapping together with a deeper understand-
ing of the contribution of merging at different levels of the 
GO tree can provide valuable insights into the factors con-
tributing to an efficient merge process. Future work in this 
direction will also enable the improvements in automatic 
annotations of poorly studied ontologies as well as im-
prove our understanding on how various ontologies are 
interrelated. 
Since our proposed framework for ontology integration in 
this study, depends on the pairwise similarity between 
every pair of UMLS terms (after mapping both ontologies 
onto the UMLS IDs) by measuring the path lengths in the 
merged hierarchy maintained tree and then optimizing the 
distance matrix, this approach can also work on ontology 
structures with multiple hierarchies. However, if the inter-
est is to merge each hierarchy (say GO process only) of a 
given ontology independently with target ontology as op-
posed to doing a combined merge - this is also possible. For 
instance, if one of the hierarchies is more completely anno-
tated it might be a preferred option to choose to merge only 
a specific branch.  Hence, given the generic nature of inte-
gration using distance matrices after merging two different 
ontologies over UMLS, this framework can be a promising 
approach for integrating a wide range of ontological struc-
tures at varying levels of resolution for knowledge discov-
ery by annotation repurposing.  
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FIGURES 
Fig. 1. Workflow showing the procedure for integrating two heterogeneous ontology trees. Panel to the left shows the mapping of a typical non-UMLS 
ontology onto UMLS CUIs using LDPmap (this step is not needed for a UMLS-based ontology) followed by using the kDLS approach for generating a 
similarity matrix between the two ontologies. Panel to the right shows the merged ontology which maintains the hierarchy of the original concepts as well as 
minimizes the score of the similarity matrix to generate a globally optimal merge. 
Fig. 2. Sub-tree from the merged ICD9 and GO tree showing the relationships and paths between various diseases (shown as ICD9 codes in green) and 
Gene Ontology terms (shown as GO terms in blue). This extracted tree highlights the various ICD9 annotations as CUIs, shows the intermediate connecting 
UMLS ids (CUIs) in grey as well as the edge types highlighted with a legend to the right. Other UMLS nodes (grey nodes) which facilitated this merge process 
in the form of shortest paths to connect these concepts are also shown.
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Fig. 3. Diseases with significant overlap in the number of genes between ICD9->GO mapping and MalaCards as well as DO annotations respectively. The 
figure shows the list of the diseases (based on ICD9 codes) that were found to be highly enriched. Each bar shows significance calculated as –log(p-value) 
of enrichment for a given ICD9/disease.
Fig. 4. In this analysis we hypothesized that the number of the genes associated with MalaCards, DO disease annotations and ICD9 codes are directly 
associated with significance of the observed results. In other words, we wanted to know the relation between the observed significance and the extent of 
annotation in the respective databases. To test this, we formed two groups, each containing the reported associations with highest and lowest significance 
and counted the number of genes reported for each pair of ICD9 code, MalaCards and DO diseases. We found that gene count was significantly higher in 
the high significance set than in the set with no significance. P-values based on Wilcoxon tests are shown under each comparison.
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Fig. 5. Association networks for (a) MalaCards and (b) Disease Ontology showing the significance of association among the ICD9 Codes based on their 
gene pool overlap. In this analysis we calculated hypergeometric p-values for every pair of ICD9 Codes of interest using our ICD9 to gene mapping and the 
associations with p-value<0.05 are shown with significance values proportional to the thickness (measured as –log(p-value) of enrichment) of the edge.
Fig. 6. Overlap of ICD9-ICD9 gene based associations with temporal relationships data obtained from Hanauer and Ramakrishnan (Hanauer and Rama-
krishnan, 2013).
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TABLES 
Table 1. Highly significant pair of ICD9-MalaCard associations (p-value<0.01). 
ICD9 Code 
(CUI) 
ICD9 Description Gene Count 
(ICD9)  
MalaCard Disease 
Name 
Gene 
Count(MalaCards) 
Signifi-
cance 
C0007102 Malignant neoplasm of colon, un-
specified 
420 colon cancer 1491 9.48E-50 
C0001308 Acute and subacute necrosis of 
liver 
148 hepatitis 3143 3.42E-34 
C0019829 Hodgkin's sarcoma 498 hodgkin's lym-
phoma 
780 3.77E-28 
C0023418 Leukemia of unspecified cell type 79 myeloid leukemia 1219 1.78E-17 
C0004096 Asthma 630 asthma 901 3.94E-16 
C0023418 Leukemia of unspecified cell type 79 chronic myeloid 
leukemia 
427 3.27E-13 
C0023418 Leukemia of unspecified cell type 79 leukemia 3411 3.75E-13 
C0019829 Hodgkin's sarcoma 498 sarcoidosis 278 1.69E-12 
C0018916 Hemangioma of unspecified site 372 hemangioma 163 1.98E-10 
C0004096 Asthma 630 allergic asthma 138 3.43E-09 
C0018916 Hemangioma of unspecified site 372 hemangioma of 
lung 
21 1.48E-07 
C0023418 Leukemia of unspecified cell type 79 acute lympho-
blastic leukemia 
783 2.31E-07 
C0023418 Leukemia of unspecified cell type 79 acute myeloid leu-
kemia 
804 3.28E-07 
C0014868 Esophagitis, unspecified 147 esophagitis 1503 4.00E-07 
C0007107 Malignant neoplasm of larynx, 
unspecified 
137 laryngeal carci-
noma 
177 9.32E-07 
C0024623 Malignant neoplasm of stomach, 
unspecified 
27 gastric cancer 2103 2.41E-06 
C0006840 Candidiasis of unspecified site 18 candidiasis 125 4.36E-06 
C0024623 Malignant neoplasm of stomach, 
unspecified 
27 stomach cancer 197 1.91E-04 
C0008370 Obstruction of bile duct 39 cholestasis 212 1.08E-03 
C0023418 Leukemia of unspecified cell type 79 acute lymphocytic 
leukemia 
112 1.43E-03 
C0019360 Herpes zoster 34 herpes zoster 36 1.52E-03 
C0023418 Leukemia of unspecified cell type 79 acute promyelocy-
tic leukemia 
231 3.12E-03 
C0023418 Leukemia of unspecified cell type 79 li-fraumeni syn-
drome 
20 3.44E-03 
C0006413 Burkitt's tumor or lymphoma 108 burkitt's lym-
phoma 
270 4.80E-03 
C0018099 Gout, unspecified 58 gout 260 6.20E-03 
C0009324 Ulcerative colitis, unspecified 142 ulcerative colitis 583 8.48E-03 
C0023448 Lymphoid leukemia 41 lymphoblastic leu-
kemia 
872 8.63E-03 
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Table 2. Highly significant pair of ICD9-DO associations (p-value<0.05) 
ICD9 
Code 
(CUI) 
ICD9 Description Gene 
Count 
DO Disease 
Name 
Gene 
Count 
Significance 
C0023418 Leukemia of unspecified cell type 79 leukemia 982 2.84E-08 
C0023418 Leukemia of unspecified cell type 79 chronic myeloid 
leukemia 
172 3.64E-06 
C0019829 Hodgkin's sarcoma 498 Hodgkin's lym-
phoma 
66 4.73E-05 
C0006413 Burkitt's tumor or lymphoma 108 lymphoma 561 1.11E-04 
C0004096 Asthma 630 asthma 351 1.24E-04 
C0023418 Leukemia of unspecified cell type 79 myeloid leukemia 367 2.48E-04 
C0019829 Hodgkin's sarcoma 498 sarcoidosis 79 2.63E-04 
C0023448 Lymphoid leukemia 41 lymphoblastic leu-
kemia 
206 5.41E-04 
C0023418 Leukemia of unspecified cell type 79 acute myeloid leu-
kemia 
388 1.52E-03 
C0004096 Asthma 630 allergic asthma 39 5.70E-03 
C0001308 Acute and subacute necrosis of liver 148 hepatitis 423 7.14E-03 
C0153392 Malignant neoplasm of nasopharynx, 
unspecified 
220 nasopharynx car-
cinoma 
196 1.99E-02 
C0018916 Hemangioma of unspecified site 372 capillary hemangi-
oma 
9 3.92E-02 
C0018916 Hemangioma of unspecified site 372 hemangioma 38 4.04E-02 
C0023418 Leukemia of unspecified cell type 79 Li-Fraumeni syn-
drome 
7 4.95E-02 
C0039075 Syndactyly 121 syndactyly 7 5.03E-02 
Table 3. Overlapping pair of ICD9-ICD9 codes with temporal relationships data obtained from Hanauer and Ramakrish-
nan [36].  
First ICD9 
(CUI) 
Second ICD9 
(CUI) 
First ICD9 Description Second ICD9 Description 
C0007102 C0018916 Malignant neoplasm of colon, un-
specified 
Hemangioma of unspecified site 
C0001308 C0008370 Acute and subacute necrosis of liver Obstruction of bile duct 
C0007102 C0004096 Malignant neoplasm of colon, un-
specified 
Asthma 
C0007102 C0024623 Malignant neoplasm of colon, un-
specified 
Malignant neoplasm of stomach, unspeci-
fied 
C0014868 C0007107 Esophagitis, unspecified Malignant neoplasm of larynx, unspecified 
C0007102 C0007107 Malignant neoplasm of colon, un-
specified 
Malignant neoplasm of larynx, unspecified 
C0007102 C0014868 Malignant neoplasm of colon, un-
specified 
Esophagitis, unspecified 
C0018916 C0006840 Hemangioma of unspecified site Candidiasis of unspecified site 
C0007102 C0006840 Malignant neoplasm of colon, un-
specified 
Candidiasis of unspecified site 
C0018916 C0014868 Hemangioma of unspecified site Esophagitis, unspecified 
C0007107 C0024623 Malignant neoplasm of larynx, un-
specified 
Malignant neoplasm of stomach, unspeci-
fied 
C0014868 C0024623 Esophagitis, unspecified Malignant neoplasm of stomach, unspeci-
fied 
C0004096 C0006840 Asthma Candidiasis of unspecified site 
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C0024623 C0006840 Malignant neoplasm of stomach, 
unspecified 
Candidiasis of unspecified site 
C0006840 C0008370 Candidiasis of unspecified site Obstruction of bile duct 
SUPPLEMENTARY MATERIAL 
Table 1. Complete paths showing the connections between ICD9 and GO terms from the sub-graph highlighted in Figure 
2. In each case the path is directed and starts with ICD9 code (UMLS id) and ends with a GO term (UMLS id) and the
edge type contributing to the association is shown in braces. This data is also shown in the form a network in the second 
tab of this excel sheet. 
